BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23313257)

  • 1. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.
    Honoré C; Goéré D; Messager M; Souadka A; Dumont F; Piessen G; Elias D; Mariette C;
    Eur J Surg Oncol; 2013 Mar; 39(3):235-41. PubMed ID: 23313257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
    Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
    Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it reasonable to treat early gastric cancer with signet ring cell histology by endoscopic resection? Analysis of factors related to lymph-node metastasis.
    Park JM; Kim SW; Nam KW; Cho YK; Lee IS; Choi MG; Chung IS; Song KY; Park CH; Jung CK
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1132-5. PubMed ID: 19369881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
    Shi C; Yang B; Chen Q; Yang J; Fan N
    Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.
    Chua TC; Pelz JO; Kerscher A; Morris DL; Esquivel J
    Ann Surg Oncol; 2009 Oct; 16(10):2765-70. PubMed ID: 19641972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is signet-ring cell carcinoma a specific entity among gastric cancers?
    Voron T; Messager M; Duhamel A; Lefevre J; Mabrut JY; Goere D; Meunier B; Brigand C; Hamy A; Glehen O; Mariette C; Paye F
    Gastric Cancer; 2016 Oct; 19(4):1027-1040. PubMed ID: 26606931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil.
    Fanelli MF; de Paiva TF; Silva MJ; Benevides CF; Guimarães AP; Gimenes DL; Pinheiro ED; Rinck JA; Nicolau UR; Sanches SM; Mello CA; Dettino AL; Cruz MR; de Melo LM; Formiga MN; de Lima VC; Chinen LT
    J Surg Oncol; 2009 Nov; 100(6):452-5. PubMed ID: 19697363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signet ring cell adenocarcinomas: different clinical-pathological characteristics of oesophageal and gastric locations.
    Piessen G; Messager M; Lefevre JH; Goéré D; Mabrut JY; Meunier B; Brigand C; Hamy A; Glehen O; Mariette C;
    Eur J Surg Oncol; 2014 Dec; 40(12):1746-55. PubMed ID: 25012732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
    Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
    ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer.
    Yano M; Yasuda T; Fujiwara Y; Takiguchi S; Miyata H; Monden M
    J Surg Oncol; 2004 Oct; 88(1):39-43. PubMed ID: 15384086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is endoscopic resection an acceptable treatment for undifferentiated EGC?
    Park J; Choi KD; Kim MY; Lee JH; Song HJ; Lee GH; Jung HY; Kim JH
    Hepatogastroenterology; 2012; 59(114):607-11. PubMed ID: 21940373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer.
    Kim BS; Oh ST; Yook JH; Kim BS
    Surgery; 2014 Jun; 155(6):1030-5. PubMed ID: 24792508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced gastric carcinoma with signet ring cell histology.
    Li C; Kim S; Lai JF; Hyung WJ; Choi WH; Choi SH; Noh SH
    Oncology; 2007; 72(1-2):64-8. PubMed ID: 18004078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology.
    Lee JH; Choi IJ; Kook MC; Nam BH; Kim YW; Ryu KW
    Br J Surg; 2010 May; 97(5):732-6. PubMed ID: 20235088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does early signet ring cell gastric carcinoma carry a worse prognosis?].
    Triboulet JP; Gronnier C; Messager M; Piessen G; Mariette C;
    Bull Acad Natl Med; 2013 Feb; 197(2):443-55; discussion 455-6. PubMed ID: 24919373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients.
    Homma Y; Ushida S; Yamada M; Kobayashi H; Suzuki K
    Ann Surg Oncol; 2010 Feb; 17(2):455-60. PubMed ID: 19847567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indication for endoscopic mucosal resection in early signet ring cell gastric cancer.
    Ha TK; An JY; Youn HK; Noh JH; Sohn TS; Kim S
    Ann Surg Oncol; 2008 Feb; 15(2):508-13. PubMed ID: 18071825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study.
    Messager M; Lefevre JH; Pichot-Delahaye V; Souadka A; Piessen G; Mariette C;
    Ann Surg; 2011 Nov; 254(5):684-93; discussion 693. PubMed ID: 22005144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General and specific prognostic factors of early gastric carcinoma treated with curative surgery.
    Isozaki H; Tanaka N; Okajima K
    Hepatogastroenterology; 1999; 46(27):1800-8. PubMed ID: 10430349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.